These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 25302613)
1. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613 [TBL] [Abstract][Full Text] [Related]
2. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167 [TBL] [Abstract][Full Text] [Related]
3. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342 [TBL] [Abstract][Full Text] [Related]
4. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187 [TBL] [Abstract][Full Text] [Related]
5. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis. Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis. Bhattacharyya S; Wang W; Tamaki Z; Shi B; Yeldandi A; Tsukimi Y; Yamasaki M; Varga J Front Immunol; 2018; 9():2434. PubMed ID: 30405628 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036 [TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis. Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144 [TBL] [Abstract][Full Text] [Related]
9. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis. Lei L; He ZY; Zhao C; Sun XJ; Zhong XN Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680 [TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591 [TBL] [Abstract][Full Text] [Related]
11. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208 [TBL] [Abstract][Full Text] [Related]
12. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
13. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice. Lei L; Zhong XN; He ZY; Zhao C; Sun XJ Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803 [TBL] [Abstract][Full Text] [Related]
14. Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis. Saigusa R; Asano Y; Taniguchi T; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sugawara K; Tsuruta D; Taniguchi T; Sato S Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15136-41. PubMed ID: 26598674 [TBL] [Abstract][Full Text] [Related]
18. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2). Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680 [TBL] [Abstract][Full Text] [Related]
19. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283 [TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]